Clinical Advances in Hematology and Oncology
Subject Categories
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 96 |
| Total Docs. (3 years) | 321 |
| Total Refs. | 1,549 |
| Total Citations (3 years) | 124 |
| Citable Docs. (3 years) | 160 |
| Citations / Doc. (2 years) | 0.47 |
| Ref. / Doc. | 16.14 |
| % Female | 39.3% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Top 10 Most Cited Articles
Frequently Asked Questions
What is the impact factor of Clinical Advances in Hematology and Oncology?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Clinical Advances in Hematology and Oncology has an SJR of 0.283 and is ranked Q3.
What is the SJR and quartile of Clinical Advances in Hematology and Oncology?
Clinical Advances in Hematology and Oncology has an SJR (SCImago Journal Rank) of 0.283 and its best quartile is Q3.
What is the H-index of Clinical Advances in Hematology and Oncology?
The H-index of Clinical Advances in Hematology and Oncology is 47, meaning 47 of its articles have each been cited at least 47 times.
Is Clinical Advances in Hematology and Oncology indexed in Scopus?
Yes. Clinical Advances in Hematology and Oncology is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.